Markets:

Overview

News

Currencies

International

Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

16.73 +0.48 (+2.95%)

Streaming Delayed Price Updated: 9:39 AM EDT, Jul 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals

January 08, 2024

From Schrödinger

Via Business Wire

AI-Focused Drug Discovery Stocks Index Up 26% In December ↗

December 29, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.

Via Talk Markets

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

December 19, 2023

From Schrödinger

Via Business Wire

Is Schrödinger Stock a Buy Now? ↗

November 02, 2023

Its groundbreaking work is winning it some powerful fans, but it's still risky.

Via The Motley Fool

These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest? ↗

December 18, 2023

2024 is going to be a sizzler in the biopharma sector.

Via The Motley Fool

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗

December 17, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event

December 14, 2023

From Schrödinger

Via Business Wire

Artificial Intelligence in Healthcare: 3 Stocks Transforming the Industry ↗

December 11, 2023

Companies are applying AI in healthcare, leading to better outcomes and stronger performance for their stocks.

Via InvestorPlace

Topics Artificial Intelligence

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗

December 11, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

December 10, 2023

From Schrödinger

Via Business Wire

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

November 17, 2023

From Schrödinger

Via Business Wire

3 Cutting-Edge Biotech Stocks for the Bold Investor ↗

November 14, 2023

With broader market concerns rising, investors may want to consider the relatively insulated allure of biotech stocks to buy.

Via InvestorPlace

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence ↗

November 09, 2023

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.

Via InvestorPlace

Topics Artificial Intelligence

Schrödinger to Participate in Upcoming Investor Conferences

November 06, 2023

From Schrödinger

Via Business Wire

3 Top Publicly Traded Companies Leading the AI Revolution ↗

November 04, 2023

Recent data indicates that AI is already saving companies a great deal of money. Here are three AI stocks to buy to exploit the trend.

Via InvestorPlace

Topics Artificial Intelligence

Schrödinger to Present New Data for SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

November 02, 2023

From Schrödinger

Via Business Wire

Schrödinger Reports Third Quarter 2023 Financial Results

November 01, 2023

From Schrödinger

Via Business Wire

Schrödinger to Host Pipeline Day on December 14, 2023

October 30, 2023

From Schrödinger

Via Business Wire

3 Bill Gates Stocks to Buy for Billionaire-Like Returns ↗

October 27, 2023

Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less.

Via InvestorPlace

This Artificial Intelligence (AI) Stock Is Powering the Biotech Revolution: Should You Invest? ↗

October 25, 2023

There's more to the AI boom than Microsoft and ChatGPT.

Via The Motley Fool

Topics Artificial Intelligence

Earnings Scheduled For November 1, 2023 ↗

November 01, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.

Via Benzinga

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

October 23, 2023

From Schrödinger

Via Business Wire

Schrödinger to Announce Third Quarter 2023 Financial Results on November 1

October 18, 2023

From Schrödinger

Via Business Wire

Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months ↗

October 16, 2023

Cathie Wood and Bill Gates like this stock, too.

Via The Motley Fool

Topics Artificial Intelligence

3 Artificial Intelligence Stocks That Could Outperform the ‘Godfather of AI’ ↗

October 09, 2023

These are the AI stocks to buy and hold for multibagger returns in the next 24 months, as they represent quality growth companies.

Via InvestorPlace

Topics Artificial Intelligence

7 Trailblazing AI Stocks to Buy on Any Weakness ↗

October 08, 2023

Investors are greatly underestimating the transformative power of AI at this point. Here are seven AI stocks to buy on weakness.

Via InvestorPlace

Topics Artificial Intelligence

3 Publicly Traded Companies Most at Risk of an AI Smackdown ↗

September 28, 2023

Investors should definitely look to sell these three companies at risk from AI. The businesses are poised to be undermined by the technology.

Via InvestorPlace

Topics Artificial Intelligence

This AI Biotech Stock Is Already Profitable. Should You Buy It? ↗

September 28, 2023

Its future could be bright, but don't get too attached to its successes right now.

Via The Motley Fool

Topics Artificial Intelligence

Schrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling Education

September 28, 2023

From Schrödinger

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.